Massachusetts-headquartered TransMedics has selected Gogo Galileo satcom for connectivity aboard its 22 Embraer Phenom 300Es, with its full U.S.-based fleet scheduled for retrofit over the coming months. The system will specifically be used to support the monitoring of human organs destined for transplantation during logistical missions.
By mid-2027, TransMedics believes it will be the first and only organ transplant company to roll out Gogo Galileo across its entire fleet—a capability it intends to extend to its European aircraft in 2028. “When you’re transporting donor organs, connectivity isn’t a convenience; it’s part of the mission,” stated Gogo CEO Chris Moore.
During a transportation flight, TransMedics uses its proprietary portable Organ Care System to maintain the viability of donated material, stating that “organs are maintained in a living, functioning state, perfused with warm, oxygenated, and nutrient-enriched blood.” According to the company, this advanced method—unlike keeping donations on ice—helps keep organs in optimum condition, while allowing constant monitoring.
TransMedics global logistics v-p Andre Costa said Gogo Galileo was selected “not only for the reliable, high-performance connectivity these critical missions demand, but also for the cybersecurity, system redundancy, and active monitoring that Gogo delivers to its customers.”
In August, TransMedics highlighted that 86% of its flight missions in the second quarter were conducted using its owned Phenom 300E fleet.
In this article
More In Operations
